Join us and register today

Stay on top of the latest trends

Key speakers

Erika Barbarosie

Erika Barbarosie

Associate Director Compliance
Daniela Santos

Daniela Santos

Head Global Drug Safety Hub
Marcin Kruk

Marcin Kruk

Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East
Carla Mateo Mohedano

Carla Mateo Mohedano

Associate Director, Patient Safety Scientist — Oncology
Bettina Wick-Urban

Bettina Wick-Urban

Senior Scientific Director Benefit Risk Management PV & PS


Key topics

  1. Cost-efficient pharmacovigilance strategies: Doing more with less
  2. Managing large amounts of data efficiently in PV
  3. Developing a pharmacovigilance risk management plan with a RiskMAP for high-risk products
  4. How can real-world evidence revolutionise traditional pharmacovigilance methods?
  5. Regulatory inspections — Avoiding critical and major findings
  6. How can we amplify patient safety through innovative practices?
  7. Good pharmacovigilance practices (GVP) implementation
  8. Signal detection and evaluation in RMPV



Who Should Attend

Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from pharma industry involved in:

  • Pharmacovigilance
  • Risk Management
  • PV Monitoring
  • Signal Detection
  • Data Collection
  • Safety Surveillance
  • Safety Evaluation
  • Patient Safety
  • Drug Safety
  • Benefit-Risk Evaluation
  • Quality Assurance
  • Compliance
  • Reporting and Data Collection
  • Compliance
  • Signal Detection
  • Pharmacovigilance Operations
  • QPPV
  • Benefit-risk Management
  • PV Writing
  • Inspections
  • PV Governance
  • Management Safety Data
  • Lifecycle Management Quality
  • Clinical Safety